Free Trial
NASDAQ:BHST

BioHarvest Sciences (BHST) Stock Price, News & Analysis

BioHarvest Sciences logo
$6.26 -0.29 (-4.43%)
As of 04/28/2025 03:59 PM Eastern

About BioHarvest Sciences Stock (NASDAQ:BHST)

Key Stats

Today's Range
$6.26
$6.97
50-Day Range
$5.03
$6.75
52-Week Range
$6.26
$7.38
Volume
20,354 shs
Average Volume
18,336 shs
Market Capitalization
$102.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00
Consensus Rating
Buy

Company Overview

BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.

Receive BHST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioHarvest Sciences and its competitors with MarketBeat's FREE daily newsletter.

BHST Stock News Headlines

BioHarvest Sciences participates in a conference call with Maxim Group
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
See More Headlines

BHST Stock Analysis - Frequently Asked Questions

BioHarvest Sciences' stock was trading at $6.18 at the start of the year. Since then, BHST shares have increased by 1.3% and is now trading at $6.26.
View the best growth stocks for 2025 here
.

BioHarvest Sciences Inc. (NASDAQ:BHST) released its quarterly earnings data on Monday, March, 31st. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.12) by $0.05. The business had revenue of $7.17 million for the quarter, compared to analysts' expectations of $7.24 million.
Read the conference call transcript
.

Top institutional shareholders of BioHarvest Sciences include Magnus Financial Group LLC (0.44%).

Shares of BHST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
3/31/2025
Today
4/29/2025
Next Earnings (Estimated)
4/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BHST
Previous Symbol
NASDAQ:BHST
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.00
High Stock Price Target
$14.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+107.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-12,560,000.00
Pretax Margin
-76.65%

Debt

Sales & Book Value

Annual Sales
$25.19 million
Price / Cash Flow
N/A
Book Value
($1.08) per share
Price / Book
-5.80

Miscellaneous

Free Float
N/A
Market Cap
$102.82 million
Optionable
N/A
Beta
0.84
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:BHST) was last updated on 4/29/2025 by MarketBeat.com Staff
From Our Partners